Concepedia

Author

Horst Böshagen

Bayer (Germany)

Also Known As

H Böshagen, H. Böshagen, Horst Böshagen

35

Publications

451

Citations

13

H-Index

21

Concepts

All Affiliations

Bayer (Germany)
HB

About

Horst Böshagen is an author at Bayer (Germany) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

105

2

Biochemistry

5

5

126

3

Natural Sciences

4

4

104

4

Biomolecular Engineering

3

3

87

5

Engineering

1

1

44

Horst Böshagen

×

7

Publications

149

Citations

7

H-Index

YearCitations

The chemistry of the 1-deoxynojirimycin system. Synthesis of 2-acetamido-1,2-dideoxynojirimycin from 1-deoxynojirimycin

Horst Böshagen, Fred-Robert Heiker, A. Matthias Schüller

Carbohydrate Research

1987

44

A new structural analogue antagonist of peptido-leukotrienes. The discovery of bay x7195

Trevor S. Abram, Horst Böshagen, Janet Butler,

Bioorganic & Medicinal Chemistry Letters

1993

22

Reaction of 1‐α‐Cyano‐1‐deoxynojirimycin with Grignard Compounds—Complete Exchange of the CN— Group

Horst Böshagen, Walter Geiger, Bodo Junge

Angewandte Chemie International Edition in English

1981

22

Synthesis and absolute configuration of the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid and comparison with its enantiomer.

Ulrich Rosentreter, Horst Böshagen, F Seuter,

PubMed

1989

21

Inhibition of platelet aggregation in vitro and ex vivo by the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.

F Seuter, Elisabeth Perzborn, Ulrich Rosentreter,

PubMed

1989

17

Action of the novel selective thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazolepropan oic acid on vascular smooth muscle preparations.

Elisabeth Perzborn, F Seuter, Volker B. Fiedler,

PubMed

1989

13

Reduction of in vivo coronary artery thrombosis by the novel thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.

Fiedler Vb, Elisabeth Perzborn, F Seuter,

PubMed

1989

10

Page 1